Adult Onset Still's Disease Presenting with Acute Respiratory Distress Syndrome: Case Report and Review of the Literature [0.03%]
成人Still病伴急性呼吸窘迫综合征1例及文献复习
Anisha B Dua,Augustine M Manadan,John P Case
Anisha B Dua
Introduction: Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder characterized by rash, leukocytosis, fevers, and arthralgias. Pulmonary involvement has been reported rarely in AOSD, but acute respirat...
Risk factors for infection following total joint arthroplasty in rheumatoid arthritis [0.03%]
类风湿关节炎患者行人工关节置换术后感染的风险因素分析
Ranjani Somayaji,Cheryl Barnabe,Liam Martin
Ranjani Somayaji
Objectives: Determine risk factors for infection following hip or knee total joint arthroplasty in patients with rheumatoid arthritis. Methods: ...
The Pathophysiology of Primary Hip Osteoarthritis may Originate from Bone Alterations [0.03%]
原发性髋关节骨关节炎的病理生理学可能起源于骨改变
Mikio Kamimura,Yukio Nakamura,Shota Ikegami et al.
Mikio Kamimura et al.
Objectives: The aim of this study was to investigate whether bone alterations detected by hip magnetic resonance imaging (MRI) were associated with subsequent primary hip OA. ...
The Effect of Socioeconomic Class and Immigrant Status on Disease Activity in Rheumatoid Arthritis: Data from BARFOT, a Multi-Centre Study of Early RA [0.03%]
社会经济地位和移民状态对类风湿关节炎患者疾病活动度的影响——来自BARFOT(一项关于早期类风湿性关节炎的多中心研究)的数据
Maria L E Andersson,Stefan Bergman,Maria K Söderlin
Maria L E Andersson
Background: There have been no reports on the effect of immigrant status and socioeconomic status on outcome in rheumatoid arthritis (RA) in Sweden. Metho...
Concomitance of IgM and IgG anti-dsDNA Antibodies Does Not Appear to Associate to Active Lupus Nephritis [0.03%]
IgM和IgG抗dsDNA抗体的共存不似乎不与活动性狼疮性肾炎相关
Briele Keiserman,Maria Rita Ronchetti,Odirlei Andre Monticielo et al.
Briele Keiserman et al.
Previous reports proposed that the IgM anti-dsDNA antibody is protective for lupus nephritis. In this cross-sectional study, we aimed to compare clinical features of systemic lupus erythematosus (SLE) patients positive for IgG anti-dsDNA al...
Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial [0.03%]
CONDOR试验中塞来昔布和联合奥美拉唑的双氯芬酸在高胃肠道风险的关节炎患者中的治疗作用相似
Herbert L Kellner,Chunming Li,Margaret N Essex
Herbert L Kellner
Objective: Compare effectiveness of celecoxib versus diclofenac plus omeprazole in improving arthritis signs and symptoms in patients at high gastrointestinal (GI) risk who were enrolled in the CONDOR (Celecoxib vs Omepra...
Fozya Bashal
Fozya Bashal
This article is a review of different management strategies for the hematological manifestations of systemic lupus erythematosus (SLE), the strategies include immunosuppressive drugs, some noval therapies and B-cell depletion for refractory...
Efficacy and Safety of Rituximab in Biologic-Naive Patients with Rheumatoid Arthritis vs Anti-Tnf Therapy Failure [0.03%]
利妥昔单抗治疗生物制剂初治类风湿关节炎患者的疗效和安全性与抗TNF治疗失败患者中的疗效和安全性比较
Luis Arturo Gutierrez-Gonzalez,Marco Antonio Rivera Gudiño,Ibell Oropeza Ceija et al.
Luis Arturo Gutierrez-Gonzalez et al.
Objectives: Our aim was to compare an AntiCD20 therapy (rituximab) for rheumatoid arthritis in two patient populations (Group 1), anti-TNFα naïve patients and inadequate responders to Anti-TNFα therapy (Group 2). ...
Joint pain undergoes a transition in accordance with signal changes of bones detected by MRI in hip osteoarthritis [0.03%]
髋关节骨关节炎患者的疼痛与磁共振成像检测到的骨信号变化有关联
Mikio Kamimura,Yukio Nakamura,Shota Ikegami et al.
Mikio Kamimura et al.
Objectives: In this study, we aimed to investigate whether joint pain is derived from cartilage or bone alterations. Methods: We review...
No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis [0.03%]
类风湿关节炎患者抗肿瘤坏死因子药物特异性IgA和IgM抗体的产生与疾病活动及不良反应无关
Maurizio Benucci,Gianantonio Saviola,Francesca Meacci et al.
Maurizio Benucci et al.
The use of tumour necrosis factor (TNF) antagonists (infliximab [IFN], etanercept [ETN], adalimumab [ADA]) has changed the course of many rheumatic diseases, including rheumatoid arthritis (RA). However, some questions concerning their safe...